Cargando…
Glyburide Regulates UCP1 Expression in Adipocytes Independent of K(ATP) Channel Blockade
Identification of safe and effective compounds to increase or activate UCP1 expression in brown or white adipocytes remains a potent therapeutic strategy to combat obesity. Here we reported that, glyburide, one of the FDA-approved drugs currently used to treat type 2 diabetes, can significantly enha...
Autores principales: | Qiu, Yan, Yang, Yuanyuan, Wei, Yuda, Liu, Xiaojian, Feng, Zhuanghui, Zeng, Xuwen, Chen, Yanhao, Liu, Yan, Zhao, Yongxu, Chen, Lanlan, Luo, Lijun, Ding, Qiurong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452185/ https://www.ncbi.nlm.nih.gov/pubmed/32829287 http://dx.doi.org/10.1016/j.isci.2020.101446 |
Ejemplares similares
-
Screening of FDA-approved drugs identifies sutent as a modulator of UCP1 expression in brown adipose tissue
por: Qiu, Yan, et al.
Publicado: (2018) -
Identification of a rhodanine derivative BML-260 as a potent stimulator of UCP1 expression
por: Feng, Zhuanghui, et al.
Publicado: (2019) -
Genetic and Chemical Screenings Identify HDAC3 as a Key Regulator in Hepatic Differentiation of Human Pluripotent Stem Cells
por: Li, Shuang, et al.
Publicado: (2018) -
Genome-scale CRISPR screening for potential targets of ginsenoside compound K
por: Yang, Yuanyuan, et al.
Publicado: (2020) -
UCP1 Dependent and Independent Thermogenesis in Brown and Beige Adipocytes
por: Ikeda, Kenji, et al.
Publicado: (2020)